Trial Watch—Small molecules targeting the immunological tumor microenvironment for cancer therapy-Reference-Cited by-同舟云学术

Trial Watch—Small molecules targeting the immunological tumor microenvironment for cancer therapy

Published:2016-03-10 Issue:6 Volume:5 Page:e1149674
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Buqué Aitziber,Bloy Norma,Aranda Fernando,Cremer Isabelle,Eggermont Alexander,Fridman Wolf Hervé,Fucikova Jitka,Galon Jérôme,Spisek Radek,Tartour Eric,Zitvogel Laurence,Kroemer Guido,Galluzzi Lorenzo

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2016.1149674

Reference370 articles.

1. Friends or foes — bipolar effects of the tumour stroma in cancer

2. Cancer prevention by targeting angiogenesis

3. The immune contexture in human tumours: impact on clinical outcome

4. The tumour microenvironment as a target for chemoprevention

5. Cancer drug resistance: an evolving paradigm

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Highly potent, orally active novel small-molecule HPK1 inhibitor DS21150768 induces anti-tumor responses in multiple syngeneic tumor mouse models;European Journal of Pharmacology;2023-12

2. Deciphering the roles of myeloid derived suppressor cells in viral oncogenesis;Frontiers in Immunology;2023-03-23

3. Plasmacytoid Dendritic Cells as a Novel Cell-Based Cancer Immunotherapy;International Journal of Molecular Sciences;2022-09-27

4. Preclinical pharmacology modeling of chimeric antigen receptor T therapies;Current Opinion in Pharmacology;2021-12

5. The Role of Metabolism in Tumor Immune Evasion: Novel Approaches to Improve Immunotherapy;Biomedicines;2021-03-31